{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:32:23Z","timestamp":1786653143842,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Biomed Res"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/2277-9175.158039","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T10:47:53Z","timestamp":1433242073000},"page":"124","source":"Crossref","is-referenced-by-count":15,"title":["Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn"],"prefix":"10.4103","volume":"4","author":[{"given":"Elham","family":"Delrish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Jabbarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2277-9175.158039-1","first-page":"228","volume-title":"Antibiotic susceptibility patterns of pseudomonas corneal ulcers in contact lens wearers","author":"Mohammadpour","year":"2011","journal-title":"Middle East Afr J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0974-9233","issn-type":"print"},{"key":"key-10.4103\/2277-9175.158039-2","first-page":"6","volume-title":"Therapeutic possibilities of ceftazidime nanoparticles in devasting pseudomonas ophthalmic infections; keratitis and endophthalmitis","author":"Mohammadpour","year":"2012","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"key-10.4103\/2277-9175.158039-3","first-page":"2","volume-title":"Emerging techniques to treat corneal neovascularisation","author":"Menzel-Severing","year":"2012","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2277-9175.158039-4","first-page":"74","volume-title":"Hemangiogenesis and lymphangiogenesis in corneal pathology","author":"Tshionyi","year":"2012","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-5","first-page":"127","volume-title":"Efficacy of Intralesional bevacizumab injection in decreasing pterygium size","author":"FallahTafti","year":"2011","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-6","first-page":"215","volume-title":"Deep intrastromalbevacizumab injection for management of corneal stromal vascularization after deep anterior lamellar keratoplasty, a novel technique","author":"Hashemian","year":"2011","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-7","first-page":"242","volume-title":"Corneal neovascularization","author":"Chang","year":"2001","journal-title":"CurrOpinOphthalmol"},{"key":"key-10.4103\/2277-9175.158039-8","first-page":"118","volume-title":"Topical and subconjunctivalbevacizumab for corneal neovascularization in an experimental rat model","author":"\u00d6ner","year":"2012","journal-title":"Ophthalmic Res"},{"key":"key-10.4103\/2277-9175.158039-9","first-page":"221","volume-title":"Corneal neovascularization: Molecular events and therapeutic options","author":"Shakiba","year":"2009","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"key-10.4103\/2277-9175.158039-10","first-page":"751","volume-title":"Nanocarriers as an emerging platform for cancer therapy","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"key-10.4103\/2277-9175.158039-11","first-page":"14","volume-title":"Antiangiogenic effect of silicate nanoparticles on corneal neovascularization induced by vascular endothelial growth factor","author":"Mohammadpour","year":"2014","journal-title":"Journal of Medical Hypotheses and Ideas"},{"key":"key-10.4103\/2277-9175.158039-12","first-page":"738","volume-title":"Penetration of silicate nanoparticles into the corneal stroma and intraocular fluids","author":"Mohammadpour","year":"2014","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-13","doi-asserted-by":"crossref","unstructured":"Barb\u00e9 C, Bartlett J, Kong LG, Finnie K, Lin HQ, Larkin M, et al. Silica particles: A novel drug-delivery system. Adv Mater 2004;1959-66.","DOI":"10.1002\/adma.200400771"},{"key":"key-10.4103\/2277-9175.158039-14","first-page":"2768","volume-title":"Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma","author":"Benezra","year":"2011","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2277-9175.158039-15","first-page":"74","volume-title":"Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions","author":"Bradbury","year":"2013","journal-title":"IntegrBiol (Camb)"},{"key":"key-10.4103\/2277-9175.158039-16","first-page":"231","volume-title":"Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: Surface functionalization, natural biodistribution, and acute toxicity","author":"Galagudza","year":"2010","journal-title":"Int J Nanomed"},{"key":"key-10.4103\/2277-9175.158039-17","first-page":"220","volume-title":"Behavior of silica particles introduced into an isolated rat heart as potential drug carriers","author":"Borak","year":"2007","journal-title":"Biomed Mater"},{"key":"key-10.4103\/2277-9175.158039-18","first-page":"19","volume-title":"Treatment of Parkinson\u2032s disease: Nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system","author":"L\u00f3pez","year":"2010","journal-title":"Int J Nanomedicine"},{"key":"key-10.4103\/2277-9175.158039-19","first-page":"784","volume-title":"Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor","author":"Jo","year":"2012","journal-title":"Nanomedicine"},{"key":"key-10.4103\/2277-9175.158039-20","first-page":"283","volume-title":"Determination of silicate in seawater by inductively coupled plasma atomic emission spectrometry","author":"Kazuo","year":"1992","journal-title":"J Oceanogr"},{"key":"key-10.4103\/2277-9175.158039-21","first-page":"1714","volume-title":"Facile preparation of highly monodisperse small silica spheres (15 to >200 nm) suitable for colloidal templating and formation of ordered arrays","author":"Hartlen","year":"2008","journal-title":"Langmuir"},{"key":"key-10.4103\/2277-9175.158039-22","first-page":"531","volume-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea","author":"Mahoney","year":"1985","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/2277-9175.158039-23","first-page":"669","volume-title":"The biology of VEGF and its receptors","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key-10.4103\/2277-9175.158039-24","first-page":"1127","volume-title":"Treating age-related macular degeneration - interaction of VEGF-antagonists with their target","author":"Klettner","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"key-10.4103\/2277-9175.158039-25","first-page":"18","volume-title":"Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2277-9175.158039-26","first-page":"1070","volume-title":"Subconjunctival and Intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy","author":"Oh","year":"2009","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-27","first-page":"1110","volume-title":"Combined use of subconjunctival and Intracorneal bevacizumab injection for corneal neovascularization","author":"Yeung","year":"2011","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-28","first-page":"347","volume-title":"The dawning era of polymer therapeutics","author":"Duncan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key-10.4103\/2277-9175.158039-29","first-page":"144","volume-title":"Nanotechnology in ocular drug delivery","author":"Sahoo","year":"2008","journal-title":"Drug Discov Today"},{"key":"key-10.4103\/2277-9175.158039-30","doi-asserted-by":"crossref","unstructured":"Bhatta RS, Chandasana H, Chhonker YS, Rathi C, Kumar D, Mitra K, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies. Int J Pharm 2012;432:105-12.","DOI":"10.1016\/j.ijpharm.2012.04.060"},{"key":"key-10.4103\/2277-9175.158039-31","first-page":"608","volume-title":"Nanomaterials for ocular drug delivery","author":"Liu","year":"2012","journal-title":"MacromolBiosci"},{"key":"key-10.4103\/2277-9175.158039-32","first-page":"3060","volume-title":"Drug release from irradiated PLGA and PLLA multi-layered films","author":"Loo","year":"2010","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/2277-9175.158039-33","first-page":"455104","volume-title":"Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties","author":"Kemp","year":"2009","journal-title":"Nanotechnology"},{"key":"key-10.4103\/2277-9175.158039-34","first-page":"169","volume-title":"Nanotechnology in medicine and relevance to dermatology: Present concepts","author":"Basavaraj","year":"2012","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2277-9175.158039-35","first-page":"645","volume-title":"Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV","author":"Singh","year":"2009","journal-title":"Gene Ther"},{"key":"key-10.4103\/2277-9175.158039-36","first-page":"4374","volume-title":"In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility","author":"Brunner","year":"2006","journal-title":"Environ SciTechnol"},{"key":"key-10.4103\/2277-9175.158039-37","first-page":"3069","volume-title":"niak A, et al.Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity?","author":"Barnes","year":"2008","journal-title":"Nano Lett"},{"key":"key-10.4103\/2277-9175.158039-38","first-page":"1657","volume-title":"Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice","author":"Liu","year":"2011","journal-title":"Biomaterials"},{"key":"key-10.4103\/2277-9175.158039-39","first-page":"177","volume-title":"The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles","author":"Cho","year":"2009","journal-title":"ToxicolLett"},{"key":"key-10.4103\/2277-9175.158039-40","first-page":"46","volume-title":"In vivobiodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics","author":"Yu","year":"2012","journal-title":"J Control Release"},{"key":"key-10.4103\/2277-9175.158039-41","first-page":"39","volume-title":"The nanosilica hazard: Another variable entity","author":"Napierska","year":"2010","journal-title":"Part FibreToxicol"},{"key":"key-10.4103\/2277-9175.158039-42","first-page":"5124","volume-title":"Hollow silica and silica-boron nano\/microparticles for contrast-enhanced ultrasound to detect small tumors","author":"Liberman","year":"2012","journal-title":"Biomaterials"},{"key":"key-10.4103\/2277-9175.158039-43","first-page":"5717","volume-title":"Impact of silica nanoparticle design on cellular toxicity and hemolytic activity","author":"Yu","year":"2011","journal-title":"ACS Nano"},{"key":"key-10.4103\/2277-9175.158039-44","first-page":"2768","volume-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","author":"Takahashi","year":"2001","journal-title":"EMBO J"},{"key":"key-10.4103\/2277-9175.158039-45","first-page":"328","volume-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","author":"Ferrara","year":"2005","journal-title":"BiochemBiophys Res Commun"},{"key":"key-10.4103\/2277-9175.158039-46","first-page":"925","volume-title":"Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia","author":"Hosseini","year":"2007","journal-title":"Med Hypotheses"},{"key":"key-10.4103\/2277-9175.158039-47","first-page":"175","volume-title":"Ocular disposition of poly-hexyl-2-cyano[3 -14 C] acrylate nanoparticles in the albino rabbit","author":"Wood","year":"1985","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2277-9175.158039-48","first-page":"6341","volume-title":"Antiangiogenic properties of silver nanoparticles","author":"Gurunathan","year":"2009","journal-title":"Biomaterials"},{"key":"key-10.4103\/2277-9175.158039-49","first-page":"e190","volume-title":"Managements for corneal neovascularization","author":"Mohammadpour","year":"2013","journal-title":"Cornea"},{"key":"key-10.4103\/2277-9175.158039-50","first-page":"109","volume-title":"Deep intrastromal injection of bevacizumab for the management of corneal neovascularization","author":"Mohammadpour","year":"2013","journal-title":"Cornea"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:14Z","timestamp":1786649534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2277-9175.158039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["158039"],"URL":"https:\/\/doi.org\/10.4103\/2277-9175.158039","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}